Olutasidenib
Product Specifications
CAS Number
1887014-12-1
Target
Isocitrate Dehydrogenase (IDH), Dehydrogenase
Related Pathways
Metabolism
Purity
0.9959
Bioactivity
Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) . Olutasidenib is a highly effective, brain penetrant, and selective inhibitor of the mutant Isocitrate dehydrogenase 1 (IDH1) (IC50: 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively) .
Smiles
C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O
Molecular Formula
C18H15ClN4O2
Molecular Weight
354.79
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-6318R-BF594-01 20 µL
Acid sphingomyelinase Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details 
bs-6318R-BF594-02 100 µL
Acid sphingomyelinase Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details ![Mouse Monoclonal LSM2 Antibody (1G7) [DyLight 755]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP2-81280IR 0.1 mL
Mouse Monoclonal LSM2 Antibody (1G7) [DyLight 755]
Sign In for Pricing
View Details 
MBS2161564-01 96 Tests
Tumor Necrosis Factor Alpha Induced Protein 6 (TNFaIP6) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details MBS2161564-02 5x 96 Tests
Tumor Necrosis Factor Alpha Induced Protein 6 (TNFaIP6) Magnetic Fluorescence Assay Kit
Sign In for Pricing
View Details